Neurocrine biosciences to present at upcoming investor conferences in september

2023 wells fargo healthcare conference on september 7 in boston morgan stanley 21st annual global healthcare conference on september 12 in new york san diego , aug. 31, 2023 /prnewswire/ -- neurocrine biosciences, inc. (nasdaq: nbix) will participate at two upcoming investor conferences in september. kyle gano, chief business development and strategy officer, and todd tushla, vice president of investor relations, will present at the 2023 wells fargo healthcare conference at 3:45 p.m.
NBIX Ratings Summary
NBIX Quant Ranking